Related Experiment Videos
Survival results depend on the staging system
D E Henson1, L Ries, E M Shambaugh
1Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, Maryland 20892.
Seminars in Surgical Oncology
|March 1, 1992
Summary
Patient outcome reporting differs between the localized, regional, and distant (LRD) staging system and the TNM staging system. While TNM offers greater prognostic precision, LRD allows for stable time trend analysis in cancer research.
Area of Science:
- Oncology
- Medical Statistics
- Cancer Research
Background:
- Accurate patient outcome assessment is crucial in oncology.
- Two common staging systems, localized, regional, and distant (LRD) and the American Joint Committee on Cancer's TNM staging system, are used to categorize cancer progression.
- These systems have distinct definitions and implications for outcome reporting.
Purpose of the Study:
- To compare patient outcome reporting using the LRD and TNM staging systems.
- To analyze the overlap and differences in stage definitions between the two systems.
- To evaluate the strengths and limitations of each system for prognosis and trend analysis.
Main Methods:
- Comparative analysis of staging system definitions.
- Review of survival rates associated with different stage groupings.
- Assessment of system suitability for time trend analysis and early detection evaluation.
Main Results:
- Significant overlap exists between LRD and TNM stage definitions, with one system's stage potentially encompassing multiple stages of the other.
- "Localized" in the LRD system generally corresponds to lower survival rates than TNM stage I for most cancer sites.
- The TNM system provides more precise prognostic information due to updated survival data and diagnostic technology.
Conclusions:
- The choice of staging system impacts patient outcome reporting.
- TNM staging enhances prognostic accuracy but hinders longitudinal trend analysis.
- LRD staging is valuable for historical trend analysis due to its stability but is less suitable for evaluating early cancer detection effectiveness.